Khiron Life Sciences Corp.: Khiron achieves United Kingdom C

In Q1 2022, Khiron expects to surpass 1 million CAD in medical cannabis revenues in the United Kingdom ("UK") aloneTotal untapped potential for cannabis patients in the UK exceeds 1M patientsSupported

Related Keywords

Mexico , Germany , United States , United Kingdom , Brazil , Colombia , Peru , Toronto , Ontario , Canada , America , Paola Ricardo , Franziska Katterbach , Khiron Europe , Alvaro Torres , Linkedin , Latam Communications , Prnewswire Khiron Life Sciences Corp , Regulation Services Provider , Khiron Life Sciences Corp , Europe Communications , Life Sciences , Latin America , European Zerenia Medical Cannabis Clinics , Chief Executive Officer , Although Khiron , Annual Information Form , Media Contact , Carolina Gomez , Peter Leis , Khiron , Life , Ciences , Orp , Chieves , United , Kingdom , Cannabis , Sales , Volume , Growth , 022 ,